bac·te·ri·o·phage

(băk-tîr′ē-ə-fāj′)

A virus that infects and lyses certain bacteria.

bac·te′ri·o·phag′ic (-făj′ĭk) adj.

bac·te′ri·oph′a·gy (-ŏf′ə-jē) n.

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

bacteriophage

(bækˈtɪərɪəˌfeɪdʒ)

(Microbiology) a virus that is parasitic in a bacterium and multiplies within its host, which is destroyed when the new viruses are released. Often shortened to: phage

bacteriophagic adj

bacteriophagous adj

Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

bac•te•ri•o•phage

(bækˈtɪər i əˌfeɪdʒ)

n.

any of a group of viruses that infect specific bacteria, usu. causing their disintegration. Also called phage.

[1920–25; < French]

bac•te`ri•o•phag′ic (-ˈfædʒ ɪk, -ˈfeɪ dʒɪk) bac•te`ri•oph′a•gous (-ˈɒf ə gəs) adj.

bac•te`ri•oph′a•gy (-dʒi) n.

bacteriophage

A virus that infects and destroys the cells of bacteria. Also called phage.

ThesaurusAntonymsRelated WordsSynonymsLegend:

Noun

bacteriophage - a virus that is parasitic (reproduces itself) in bacteria; "phage uses the bacterium's machinery and energy to produce more phage until the bacterium is destroyed and phage is released to invade surrounding bacteria"

phage

virus - (virology) ultramicroscopic infectious agent that replicates itself only within cells of living hosts; many are pathogenic; a piece of nucleic acid (DNA or RNA) wrapped in a thin coat of protein

coliphage - a bacteriophage that infects the bacterium Escherichia coli

typhoid bacteriophage - a bacteriophage specific for the bacterium Salmonella typhi

Translations

Bakteriophage

bacteriófago

bactériophage

batteriofago

bacteriophage

[bækˈtɪəriəfeɪdʒ] n → bactériophage m

Collins English/French Electronic Resource. © HarperCollins Publishers 2005

Mentioned in

References in periodicals archive

Fischetti, "Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme," Proceedings of the National Academy of Sciences of the United States of America, vol.

Bacteriophages and Their Immunological Applications against Infectious Threats

Bacteriophage Stability at Acidic and Alkaline pH, at High Temperatures, and in Cold Storage.

Isolation and Physiomorphological Characterization of Escherichia coli O157:H7-Infecting Bacteriophages Recovered from Beef Cattle Operations

Bacteriophage titers were determined using the double layer agar plaque assay.

Isolation of lytic bacteriophages for nanobiocontrol of pathogenic and antibiotic resistant Salmonella present in poultry in Ecuador

Bacteriophage proponents, though, assert that the theoretical risk of harm in using this technology to cure disease is low compared to the potential gains.

Drinking diarrhea to save lives

Rapid molecular biology methods can be used to create vast libraries of proteins displayed on bacteriophage that also encapsulate the encoding DNA, they explain.

Phage Display in Biotechnology and Drug Discovery, 2nd Edition

Isolation of Shigella sonnei lysogenic for a bacteriophage encoding gene for production of Shiga toxin.

Characterization of Shigella sonnei isolate carrying Shiga toxin 2-producing gene

(NYSE American: ARMP), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that it will host a Key Opinion Leader (KOL) meeting on phage-based therapeutics for the treatment of antimicrobial-resistant infections on June 26 from 12:00 - 1:30 PM EDT in New York City.

Armata Pharmaceuticals to Host Key Opinion Leader Meeting on Bacteriophage-Based Therapeutics on June 26 in New York

The paper, entitled "Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient," appears in the peer-reviewed journal Infection.

Armata jumps after journal publishes treatment of cystic fibrosis patient

AmpliPhi Biosciences is a clinical-stage biotechnology company focussed on the development of precisely targeted bacteriophage therapeutics for antibiotic-resistant infections.

AmpliPhi Biosciences, C3J Therapeutics Close Merger to Expand Bacteriophage Therapeutics Development

M2 PHARMA-April 3, 2019-C3J Therapeutics Issued US Patent Covering Synthetic Bacteriophage

C3J Therapeutics Issued US Patent Covering Synthetic Bacteriophage

Bacteriophage, Titer, PFU, Liquid nitrogen freezing, Storage.

Short Communication - Storage of Bacteriophages at 4AdegC Leads to no Loss in Their Titer after One Year